Correlation does not equal causation. Every cancer cell has genetic mutations, but not all of those mutations necessarily ...
New research links DNA and language diversity, showing that isolated populations consistently develop more varied language ...
Alvotech (ALVO) delivered earnings and revenue surprises of -28.57% and -22.19%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com on MSN
Qiagen (QGEN) Q1 Earnings and Revenues Lag Estimates
Qiagen (QGEN) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.58 per share a year ago. These figures are ...
Net product revenues for the first quarter 2026 totaled $330.5 million, consisting of $102.0 million of ELEVIDYS net product revenue and $228.6 million of PMO net product revenuesAchieved GAAP and non ...
Zacks.com on MSN
UGI (UGI) Misses Q2 Earnings and Revenue Estimates
UGI (UGI) came out with quarterly earnings of $2.09 per share, missing the Zacks Consensus Estimate of $2.27 per share. This compares to earnings of $2.21 per share a year ago. These figures are ...
United News of Bangladesh on MSN
India's 'Twin Town' returns to spotlight with viral campaign
Dhaka, May 7 -- Tucked away in Kerala's Malappuram district, the quiet village of Kodinhi appears like any other rural settlement at first sight. But a closer look reveals an unusual pattern that has ...
Urogen Pharma (URGN) delivered earnings and revenue surprises of +16.44% and +16.96%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com on MSN
Xperi (XPER) Q1 Earnings and Revenues Surpass Estimates
Xperi (XPER) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.16 per share a year ago. These figures are ...
Digital distractions are vying for people’s focus, but our underlying capacity to pay attention seems to be undiminished.
Zacks Investment Research on MSN
TG Therapeutics (TGTX) Q1 earnings lag estimates
TG Therapeutics (TGTX) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.03 per share a year ago. These ...
Pre-industrial pollution from coal smoke and wood-burning in regions like the southeastern U.S. and UK may have made the air ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results